Filing Details

Accession Number:
0001209191-12-052295
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-11-08 16:21:39
Reporting Period:
2012-11-07
Filing Date:
2012-11-08
Accepted Time:
2012-11-08 16:21:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1215126 G Margaret Mcglynn C/O Vertex Pharmaceuticals Incorporated
130 Waverly St.
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-11-07 1,000 $45.50 1,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Open market purchases reported on this line occurred at a weighted average price of $45.50 (range $45.22 to $45.71).
  2. Ms. McGlynn undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.